Spain· ES:60634
IOPIMAX 5 mg/ml COLIRIO EN SOLUCION
A medicinal product containing apraclonidina, registered in Spain by Essential Pharma Limited.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- apraclonidina
- Manufacturer
- Essential Pharma Limited
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo6873355EUR 14.36
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Apraclonidina in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomApraclonidine 1% eye drops 0.25ml unit dose preservative freeA A H Pharmaceuticals Ltd
- NetherlandsIopidine 1,0% 10 mg/ml, oogdruppels, oplossingEssential Pharma (M) Limited
- SwitzerlandIopidine
- FranceIOPIDINE 0,5 %, collyre en solutionESSENTIAL PHARMA (M) (MALTE)
- United StatesApraclonidineSandoz Inc
- CanadaIOPIDINEESSENTIAL PHARMA SWITZERLAND GMBH
- FinlandIopidineEssential Pharma Ltd
- IrelandIOPIDINE 1%w/v Eye Drops, SolutionEssential Pharma Limited
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Iopidine
- Belgium · Iopidine
- Germany · Iopidine®
- Denmark · Iopidine
- Finland · Iopidine
- France · Iopidine
- United Kingdom (Northern Ireland) · Apraclonidine, Apraclonidine Essential Pharma
- Greece · Iopidine
- Ireland · Iopidine
- Italy · Iopidine
- Luxembourg · Iopidine
- Malta · Iopidine
- Netherlands · Iopidine
- Norway · Iopidine
- Portugal · Iopidine
- Sweden · Iopidine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2757c7b7-7f1d-4f7c-a1d4-cfc908a9f461 GET /v1/drugs/2757c7b7-7f1d-4f7c-a1d4-cfc908a9f461?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":844120800000}",
"nregistro": "60634",
"substance": "apraclonidina"
}See everything about apraclonidina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.